In addition, SCFA has the function of inducing the secretion of GLP-1 (glucagon-like peptide-1), which improves blood glucose levels and reduces insulin resistance in type I diabetes, while stimulating insulin secretion in type 2 diabetes. Here, GCG is linked to type 2 diabetes mellitus.